Ferrous Fumarate Specifications and Certificate of Analysis for Quality Assurance
application 2025-12-22
Ferrous Fumarate Specification and COA: Key Quality Parameters
Introduction
Ferrous fumarate is a widely used iron supplement known for its high bioavailability and effectiveness in treating iron deficiency anemia. Manufacturers and suppliers must adhere to strict ferrous fumarate specifications to ensure product quality, safety, and regulatory compliance. A Certificate of Analysis (COA) provides essential verification of these specifications.
Key Ferrous Fumarate Specifications
1. Chemical Purity (Assay) – Typically, pharmaceutical-grade ferrous fumarate should contain 97.0%–101.0% of the active ingredient (C₄H₂FeO₄).
2. Iron Content – The iron (Fe) content should be 32.5%–33.5%, ensuring proper potency.
3. Heavy Metals – Limits for lead (≤10 ppm), arsenic (≤3 ppm), and other heavy metals must comply with USP/EP/BP standards.
4. Loss on Drying (LOD) – Moisture content should be ≤2.0% to prevent degradation.
5. Particle Size & Solubility – Must meet pharmacopeial requirements for dissolution and absorption.
Importance of COA for Ferrous Fumarate
A Certificate of Analysis (COA) is a critical document that confirms a batch meets the required ferrous fumarate specifications. It includes:
– Batch number & manufacturing date
– Test results (assay, heavy metals, microbial limits)
– Regulatory compliance (USP, EP, or BP standards)
– Third-party lab verification (if applicable)
Conclusion
Ensuring compliance with ferrous fumarate specifications and obtaining a valid COA is essential for manufacturers, suppliers, and pharmaceutical companies. This guarantees product efficacy, safety, and regulatory approval for global markets.